Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Dandruff (Seborrhoeic Dermatitis) — Causes, Symptoms & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

Updated: 2026-07-06
Ad — after-intro

Quick Facts

Type
Dermatological condition (scalp)
Specialist
Dermatologist / GP
Key Treatment
Antifungal shampoos: ketoconazole 2% (Nizoral), zinc pyrithione, selenium sulphide 2.5%, coal tar; topical corticosteroids for inflammatory seborrhoeic dermatitis
Prevalence
Affects approximately 50% of adults globally at some point; seborrhoeic dermatitis (more severe form) affects 3-5% of the population; peaks in adolescence/early adulthood and after age 50

Overview: Dandruff and Seborrhoeic Dermatitis

Dandruff (pityriasis simplex capitis) is an extremely common scalp condition characterised by chronic or recurrent white or greyish flaking of the scalp skin, often accompanied by itch. Seborrhoeic dermatitis is the more inflammatory form — affecting the scalp and characteristically also sebaceous gland-rich areas of the face (eyebrows, nasolabial folds, ears, eyelids) and chest. Both conditions are driven by the same pathophysiological process: overgrowth of Malassezia (formerly Pityrosporum) yeast species — particularly M. globosa and M. restricta — on sebaceous skin, leading to irritant fatty acid production, enhanced skin cell turnover, and inflammation. Dandruff affects up to 50% of the global adult population — making it one of the most prevalent dermatological conditions — though most cases are mild and manageable. It is not contagious or caused by poor hygiene.

Causes & Risk Factors

The primary cause is Malassezia yeast (part of normal skin flora that becomes pathogenic in susceptible individuals) metabolising sebum lipids into oleic acid and other free fatty acids, which penetrate the stratum corneum and trigger an inflammatory response and accelerated keratinocyte turnover (desquamation — shedding). Risk factors: male sex (androgens stimulate sebaceous gland activity — dandruff is more common and severe in men), sebaceous skin type, Parkinson's disease (dramatically increased seborrhoeic dermatitis prevalence — up to 50-60% — due to seborrhoea from autonomic dysfunction and dopaminergic deficit), HIV/AIDS (severe, difficult-to-treat seborrhoeic dermatitis in immunosuppressed patients — often the presenting dermatological sign), other neurological conditions (epilepsy, head injury, spinal cord injury), emotional stress (exacerbates disease), cold dry weather (worsens symptoms in winter, improves in summer with UV exposure), infrequent shampooing (allows scale build-up), and certain medications.

Symptoms & Signs

Scalp dandruff: white or greyish loose, dry flakes falling from the scalp onto hair and clothing (most visible on dark clothing), associated scalp itch (pruritus — often mild to moderate), and scalp dryness. Seborrhoeic dermatitis of the scalp: in addition to flaking, well-defined red, greasy-looking patches with yellowish-white adherent scales distributed in the hair-bearing areas of the scalp, scalp margins, and behind the ears. Facial seborrhoeic dermatitis: erythema, scaling, and greasy crusts affecting eyebrows (brow scaling), nasolabial folds (skin creases beside the nose), external ear canal, eyelid margins (seborrhoeic blepharitis — crusting and redness of the eyelid margins), and hairline. Trunk seborrhoeic dermatitis: oval, scaly, erythematous patches in a 'petaloid' or 'Christmas tree' distribution on the chest and upper back. The condition is typically chronic with remissions and flares, rather than a single episode.

Diagnosis & Tests

Dandruff and seborrhoeic dermatitis are diagnosed clinically — no investigations are required in typical presentations. The clinical picture — characteristic distribution (scalp, face in sebum-rich areas, chest), greasy yellowish scale, and associated erythema — is diagnostic. Scalp dermoscopy: reveals follicular plugging, yellow scale, and superficial perifollicular vessels in seborrhoeic dermatitis. Differentiation from other scalp conditions: Psoriasis — well-demarcated, thicker, dry, silvery-white scaling plaques; Koebner phenomenon; may have nail and joint involvement. Tinea capitis (scalp ringworm) — patchy alopecia, scaling, broken hairs; more common in children; confirm with scalp skin scrapings and fungal culture/microscopy. Contact dermatitis — history of new hair products or dyes; eczematous rather than scaly. Atopic eczema — personal or family history; flexural distribution. Skin biopsy is rarely needed but shows spongiosis with neutrophilic exocytosis in seborrhoeic dermatitis.

Treatment Options

Medicated antifungal shampoos are the mainstay of treatment for dandruff and scalp seborrhoeic dermatitis: Ketoconazole 2% shampoo (Nizoral) — most effective antifungal agent; initially 2x weekly for 4 weeks (leave on for 3-5 minutes), then weekly for maintenance; reduces Malassezia burden directly. Zinc pyrithione shampoo (Head and Shoulders Active or prescription formulations): antibacterial and antifungal; gentler; can be used 3x weekly long-term. Selenium sulphide 2.5% shampoo: antifungal and sebum-reducing; leave on for 2-5 minutes; effective but can discolour blonde or chemically treated hair. Coal tar shampoo: anti-inflammatory, antiproliferative, antifungal; effective but malodorous; may stain. Ciclopirox olamine shampoo: broad-spectrum antifungal; good evidence for seborrhoeic dermatitis. Topical corticosteroids (scalp preparations — betamethasone valerate 0.1% lotion, fluocinolone acetonide shampoo) for inflamed, symptomatic seborrhoeic dermatitis: reduce erythema and itch; use intermittently to avoid skin atrophy. Facial seborrhoeic dermatitis: ketoconazole 2% cream or miconazole cream applied to affected areas; low-potency topical corticosteroids (hydrocortisone 1%) for short-term itch control; calcineurin inhibitors (tacrolimus 0.1% ointment, pimecrolimus 1% cream) are steroid-sparing options for facial disease (avoid corticosteroid side effects on face). Selenium sulphide or sodium sulphacetamide lotions for trunk disease.

Complications

Secondary bacterial infection (severe seborrhoeic dermatitis with extensive crusting and excoriation can become secondarily infected with Staphylococcus aureus — presenting as impetiginised, crusted, weeping dermatitis requiring topical or oral antibiotic treatment). Seborrhoeic blepharitis (seborrhoeic dermatitis affecting the eyelid margins — causes chronic eye irritation, recurrent conjunctivitis, and meibomian gland dysfunction; treated with lid hygiene, topical antibiotics, and occasionally oral tetracyclines for severe cases). Alopecia (severe long-standing scalp seborrhoeic dermatitis with significant inflammation and intense scratching may cause temporary hair shedding — telogen effluvium — which is generally reversible with effective treatment of the scalp condition). Psychosocial impact (visible scalp and facial scaling on darker skin tones causes significant embarrassment, reduced self-confidence, and social withdrawal — quality of life impact can be disproportionate to clinical severity, warranting psychological support alongside medical treatment).

Prevention & Lifestyle Management

Regular shampooing: washing the scalp 2-3 times weekly with an antifungal or anti-dandruff shampoo prevents Malassezia build-up and scale accumulation. Do not leave shampoo on for less than 3-5 minutes — adequate contact time is essential for efficacy. Rotating between two different active ingredients (e.g., ketoconazole and zinc pyrithione) every few months prevents tolerance and maintains efficacy. Maintain the scalp clean but avoid over-washing with harsh regular shampoos that may disrupt the scalp's natural barrier. Reduce stress — a well-established trigger for flares. Sunlight (UV radiation) has a mild beneficial effect on seborrhoeic dermatitis — some controlled outdoor exposure may help. Avoid thick, occlusive hair oils (coconut oil, mineral oil) which provide substrate for Malassezia growth. Hair gel, wax, and pomades can similarly worsen dandruff — use sparingly. In patients with HIV or Parkinson's disease, more aggressive and frequent antifungal treatment is needed.

When to Seek Medical Attention

See a GP or dermatologist if: dandruff or scalp scaling is severe or not improving after 4-6 weeks of regular use of over-the-counter antifungal shampoo, the scalp is very inflamed, itchy, or crusted, there is hair loss associated with the scalp condition, facial involvement (seborrhoeic dermatitis of eyebrows, nasolabial folds, or eyelids) requires treatment, or the diagnosis is uncertain. Seek urgent review if you are immunocompromised (HIV, organ transplant) and develop extensive seborrhoeic dermatitis — this may indicate significant immunosuppression. Tinea capitis (fungal scalp infection causing hair loss in children) is a medical condition distinct from dandruff and requires oral antifungal treatment — always see a doctor for scalp scaling with hair loss in a child.

Frequently Asked Questions

Simple dandruff (pityriasis simplex capitis) does not directly cause hair loss. However, severe scalp inflammation in seborrhoeic dermatitis — with intense scratching, scale build-up, and follicular inflammation — can potentially disrupt the hair growth cycle and cause temporary shedding (telogen effluvium). This is generally mild and reversible with effective treatment of the scalp condition. Hair loss associated with scalp scaling should be assessed by a dermatologist to exclude tinea capitis (scalp ringworm), which does cause hair loss and alopecia in children and adults, or other dermatological conditions (lichen planopilaris, discoid lupus erythematosus) which cause scarring alopecia. Effective antifungal treatment of seborrhoeic dermatitis does not typically cause hair loss.
No — dandruff is primarily caused by Malassezia yeast overgrowth and individual susceptibility, not by dirt or poor hygiene. People with dandruff are not less clean than those without it. However, infrequent shampooing can allow scale and sebum to accumulate on the scalp, providing more substrate for Malassezia and worsening visible flaking. Paradoxically, washing hair too frequently with harsh shampoos can also disrupt the scalp microbiome and barrier function. The most helpful approach is regular use (2-3 times per week) of antifungal or medicated anti-dandruff shampoos with adequate contact time. Dandruff is a dermatological condition with a well-established aetiology — it is not a reflection of cleanliness.
Yes — ketoconazole 2% shampoo can be used long-term for maintenance control of dandruff and seborrhoeic dermatitis. After an initial treatment course (twice weekly for 4 weeks), once-weekly use for maintenance is both effective and safe for ongoing scalp control. Topical ketoconazole has negligible systemic absorption from scalp use — the safety concerns associated with oral ketoconazole (hepatotoxicity) do not apply to the shampoo. Resistance to ketoconazole in Malassezia is not a clinically significant concern. Alternating between antifungal shampoos with different active ingredients (e.g., ketoconazole and zinc pyrithione) can maintain long-term efficacy. If seborrhoeic dermatitis flares despite regular maintenance treatment, a short course of more intensive treatment (twice weekly ketoconazole + topical steroid) usually restores control.
Dandruff (seborrhoeic dermatitis) and scalp psoriasis can be difficult to distinguish clinically. Key differences: Dandruff/seborrhoeic dermatitis: looser, more powdery, yellowish-white greasy scales; ill-defined erythema; affects hairline and face (eyebrows, nasolabial folds) as well as scalp; responds well to antifungal shampoos; often milder symptoms. Scalp psoriasis: thicker, silvery-white dry scales that are firmly adherent; well-demarcated, bright-red plaques; often extends beyond the hairline onto the nape and ears as clear-cut plaques; associated with psoriasis elsewhere (knees, elbows, nails — pitting, onycholysis); less responsive to antifungal treatment; treated with coal tar, calcipotriol (vitamin D analogue), or topical corticosteroids. Overlap (sebopsoriasis) occurs. Dermoscopy and biopsy may be needed in atypical cases.

References

  1. Borda LJ, Wikramanayake TC — Seborrheic Dermatitis and Dandruff: A Comprehensive Review, Journal of Clinical and Investigative Dermatology 2015
  2. Hay RJ — Malassezia, Dandruff and Seborrhoeic Dermatitis: An Overview, British Journal of Dermatology 2011
  3. NICE Clinical Knowledge Summary — Seborrhoeic Dermatitis, Updated 2023
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-07-06

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.